Article
Lipoprotein(a) and Cardiovascular-Kidney-Metabolic Syndrome: Stage-Specific Associations With All-Cause Mortality and Major Adverse Cardiovascular Events in the UK Biobank
2026-08-06
Abstract excerpt
<title>Abstract</title> <p>Background The American Heart Association recently introduced cardiovascular-kidney-metabolic (CKM) syndrome to describe the interrelated progression of adiposity, metabolic risk factors, chronic kidney disease, and cardiovascular disease. Lipoprotein(a) [Lp(a)] is a largely genetically determined cardiovascular risk factor, but whether its prognostic relevance differs across CKM stage...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cfb9f9a1-302e-5719-a973-730c37dedede
- DOI
- 10.21203/rs.3.rs-10033620/v1
